Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4240489
Max Phase: Preclinical
Molecular Formula: C36H26Br2Cl2N4
Molecular Weight: 585.54
Molecule Type: Small molecule
Associated Items:
ID: ALA4240489
Max Phase: Preclinical
Molecular Formula: C36H26Br2Cl2N4
Molecular Weight: 585.54
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Clc1ccc2c(c1)c1cc[n+](Cc3ccccc3)cc1n2-n1c2ccc(Cl)cc2c2cc[n+](Cc3ccccc3)cc21.[Br-].[Br-]
Standard InChI: InChI=1S/C36H26Cl2N4.2BrH/c37-27-11-13-33-31(19-27)29-15-17-39(21-25-7-3-1-4-8-25)23-35(29)41(33)42-34-14-12-28(38)20-32(34)30-16-18-40(24-36(30)42)22-26-9-5-2-6-10-26;;/h1-20,23-24H,21-22H2;2*1H/q+2;;/p-2
Standard InChI Key: MVYKJYMXJGTZEK-UHFFFAOYSA-L
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 585.54 | Molecular Weight (Monoisotopic): 584.1524 | AlogP: 8.19 | #Rotatable Bonds: 5 |
Polar Surface Area: 17.62 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 0 |
#RO5 Violations: 2 | HBA (Lipinski): 4 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: -0.38 | CX LogD: -0.38 |
Aromatic Rings: 8 | Heavy Atoms: 42 | QED Weighted: 0.18 | Np Likeness Score: -0.34 |
1. Suzuki K, Nomura I, Ninomiya M, Tanaka K, Koketsu M.. (2018) Synthesis and antimicrobial activity of β-carboline derivatives with N2-alkyl modifications., 28 (17): [PMID:30001916] [10.1016/j.bmcl.2018.06.050] |
Source(1):